TURKISH JOURNAL OF UROLOGY, cilt.46, sa.1, ss.13-17, 2020 (ESCI)
Objective: To compare human menopausal gonadotropin (hMG) and recombinant follicle-stimulating hormone (rFSH) with respect to successful spermatogenesis and pregnancy outcomes in patients with congenital hypogonadotropic hypogonadism (CHH).